- Report
- April 2022
- 555 Pages
Global
From €2280EUR$2,500USD£1,922GBP
- Book
- December 2018
- 245 Pages
- Report
- August 2023
- 435 Pages
Global
From €2279EUR$2,499USD£1,921GBP
€3256EUR$3,570USD£2,745GBP
- Report
- August 2023
- 295 Pages
Global
From €2279EUR$2,499USD£1,921GBP
€3256EUR$3,570USD£2,745GBP
- Report
- November 2021
- 185 Pages
Global
From €2370EUR$2,598USD£1,998GBP
€3386EUR$3,712USD£2,854GBP
- Book
- February 2024
- 928 Pages
- Book
- March 2023
- 1056 Pages
- Book
- February 2023
- 448 Pages
- Book
- April 2022
- 480 Pages
- Book
- January 2022
- 624 Pages
- Book
- March 2021
- 320 Pages
- Book
- October 2019
- 472 Pages
- Book
- September 2019
- 272 Pages
- Book
- September 2019
- 392 Pages
- Book
- September 2018
- 576 Pages
- Book
- August 2018
- 816 Pages

The Drug Candidate market is a subset of the Drug Discovery industry, which focuses on the development of new drugs and treatments. It involves the identification, testing, and validation of potential drug candidates that can be used to treat a variety of diseases. The process of drug discovery is complex and involves a variety of steps, including target identification, lead optimization, preclinical testing, and clinical trials.
The Drug Candidate market is highly competitive, with a number of companies vying for the best drug candidates. Companies in the market include pharmaceutical companies, biotechnology companies, and contract research organizations. These companies are involved in the research and development of new drugs, as well as the production and marketing of existing drugs. They also provide services such as drug discovery, drug development, and clinical trials. Show Less Read more